Trial NCT03906448

View at ClinicalTrials.gov 
Org. Study IDs: IRB201800600
Secondary IDs: OCR17711

Last trial update was posted on 2021-09-23

MeSH Interventions

Temozolomide

MeSH Conditions

Astrocytoma

Other Conditions

Astrocytoma, Grade II Astrocytoma, Grade III

Stopping Reasons

The study was terminated because the Study Chair/IDE Sponsor and Novocure determined that conducting this trial was not feasible without CMS approval.

Limitations And Caveats

This multicenter center study was terminated early by mutual decision between the Study Chair/IDE Sponsor and Novocure; therefore, statistical analysis of the 1 participant in the intervention arm was not done.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID